Access Bio Signs Supply Contract for COVID-19 Diagnostic Kits Worth 77 Billion KRW

[Asia Economy Reporter Minji Lee] Access Bio announced on the 25th that it has signed a supply contract for COVID-19 antigen test kits with Intrivo Diagnostics, a medical device distribution company. The contract amount is 76.944 billion KRW, which is 178% of the sales revenue as of the end of 2019.